-+ 0.00%
-+ 0.00%
-+ 0.00%

ORIC PHARMACEUTICALS - ENOZERTINIB WELL TOLERATED WITH NO GRADE 4/5 TRAES OR TREATMENT DISCONTINUATIONS

Reuters·10/23/2026 07:15:00

Please log in to view news